Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Phase 1/2 × Anlotinib × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 61 Colorectal Neoplasms 36 Breast Neoplasms 34 Ovarian Neoplasms 33 Neoplasms 32 Prostatic Neoplasms 27 Neoplasm Metastasis 27 Pancreatic Neoplasms 25 Leukemia, Myeloid, Acute 25 Melanoma 24 Multiple Myeloma 23 Lung Neoplasms 21 Recurrence 20 Endometrial Neoplasms 20 Triple Negative Breast Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 18 Lymphoma, Non-Hodgkin 18 Lymphoma 17 Lymphoma, Large B-Cell, Diffuse 16 Stomach Neoplasms 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Myelodysplastic Syndromes 15 Uterine Cervical Neoplasms 14 Carcinoma, Renal Cell 14 Leukemia, Lymphocytic, Chronic, B-Cell 13 Glioblastoma 13 Lymphoma, Follicular 12 Small Cell Lung Carcinoma 11 Lymphoma, B-Cell 11 Carcinoma, Hepatocellular 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡